Pr. Commissioner of Income-tax-21, Delhi v. M/s. Remfry & Sagar

1. FACTS OF THE CASE

Early-hearing applications in seven Revenue appeals were allowed without objection. The framed questions concerned the deduction of licence fees for goodwill, the Bar Council restrictions and Explanation 1 to section 37, including the alleged device of using goodwill. Revenue conceded that the questions were covered by Remfry & Sagar, 2025:DHC:9183-DB, in ITAs 525–528 and 531/2025. That decision, reproduced here, followed ITA 199/2017.

Source: Paragraphs 1–7; PDF pp.1–3

2. DISCUSSION BY THE COURT

The adopted reasoning applies the principal-purpose test: the consideration bought use of valuable goodwill attached to the Remfry & Sagar name. A percentage of billing measured the licence fee rather than sharing professional remuneration. Questioning the motive behind the gift of goodwill was extraneous to the expenditure under scrutiny. Apex Laboratories was distinguished by its express medical-regulation prohibition. Revenue’s present concession and parity of reasoning led to dismissal.

Source: Paragraph 7 quoting earlier paragraphs 26–36, and paragraph 8; PDF pp.8–12

3. JUDICIAL DECISION

The framed substantial questions were decided against Revenue and for the assessee. ITAs 200, 201, 207, 208, 209, 210 and 211/2017 were all dismissed.

Source: Paragraphs 8–9; PDF p.12

4. OUTCOME

The goodwill licence-fee relief challenged in these seven appeals survived. This order does not supply a year-by-year deduction amount or determine a new professional-disciplinary proceeding.

Source: Questions and operative conclusion; PDF pp.2,12

5. Expert Comments

AKHB editorial analysis, distinct from the Court’s findings.

Identify what the payment buys, not only how it is calculated

The adopted distinction is between consideration for exploiting goodwill and an arrangement to divide professional remuneration. Revenue-linked calculation alone did not establish prohibited sharing on these facts. For another agreement, its actual rights, commercial purpose and payment obligations matter; calling a payment a licence fee does not itself reproduce this case’s factual foundation.

Source: PDF p.9 · PDF p.10 · PDF p.11

A purpose test does not remove an express prohibition

The Court’s reasoning rejected a prohibited-purpose characterisation of this goodwill payment and distinguished Apex Laboratories because of the specific medical regulation there. It does not hold that professional regulations are always irrelevant to section 37 or that any expenditure with a business benefit escapes Explanation 1.

Source: PDF p.8 · PDF p.9 · PDF p.12

Preserve the chain of decisions and the seven dockets

This is a common disposal applying the earlier five-appeal decision, itself reproducing ITA 199/2017. The nested paragraph numbers belong to those quoted reasons, not to fresh paragraphs of this order. The seven present appeals remain distinct dockets; their assessment-year allocation and historical gift dates require the underlying records rather than inference from the quotations.

Source: PDF p.2 · PDF p.3 · PDF p.12